In view of its role in tumor life processes, migration, and angiogenesis as indicated above, CDH12 is a potential marker for the characterization of the patient’s condition, and CDH12 determinations have been carried out to date using several immunochemical methods (including ELISA) and semiquantitative Western blot. This evidence concerns the gene CDH12 and neoplasm.